Bio Vitos Pharma AB (publ) appoints LAGO KAPITAL as liquidity provider
Bio Vitos Pharma AB (publ) (”Bio Vitos”) has entered into a liquidity provider agreement with Lago Kapital (”LAGO”). According to the agreement, LAGO undertakes to continuously quote prices on both the buy- and sell side for Bio Vitos share in accordance with the framework of Nasdaq Stockholm´s rules for liquidity […]